SEC Company Response from BOSTON SCIENTIFIC CORP (BSX) (CIK 0000885725) (BSX) — Jan 17, 2006
BOSTON SCIENTIFIC CORP (BSX) (CIK 0000885725)
Date: Jan. 17, 2006 · CIK: 0000885725 · Accession: 0001072613-06-000078
AI Filing Summary & Sentiment
File numbers found in text: 001-11083
Referenced dates: December 30, 2005, December 7, 2005
Show Raw Text
CORRESP
1
filename1.htm
WWW.EXFILE.COM, INC. -- 14087 -- BOSTON SCIENTIFIC CORP. -- CORRESPONDENCE FILING
January
17, 2006
Mr.
Brian
Cascio
Accounting
Branch Chief
United
States Securities and Exchange Commission
100
F
Street, N.E.
Washington,
D.C. 20549-6010
Re:
Boston
Scientific Corporation
Form
10-K for Fiscal Year Ended December 31, 2004
Filed
March 16, 2005
Response
Letter dated December 7, 2005
File
No. 001-11083
Dear
Mr.
Cascio:
This
letter is in response to your letter dated December 30, 2005 regarding the
above
subject matter. For ease of reference, we have reproduced the Staff’s comments
below with our response.
Form
8-K dated October 14, 2005
Exhibit
99.1
Third
Quarter Financial Results
1.
Please
refer to prior comment 2. Your proposed revised disclosures related
to the
non-GAAP measures do not include all
of the disclosures required by paragraph (e)(1)(i) of Item 10 of
Regulation S-K and Question 8 of the FAQ Regarding the Use of Non-GAAP
Financial Measures dated June 13, 2003. Please revise to
specifically
include a discussion, in sufficient detail, of the following for
each
non-GAAP measure:
·
The
substantive reasons why management believes each non-GAAP measure
provides
useful information to
investors;
·
The
specific manner in which management uses each non-GAAP measure to
conduct
or evaluate its business;
·
The
economic substance behind management’s decision to use each measure;
and
·
The
material limitations associated with the use of each non-GAAP measure
as
compared to the use of the most directly comparable
GAAP
measure
and the manner in which management compensates for these limitations
when
using the non-GAAP measure.
Your
current disclosures are generic and vague and do not provide the reader
sufficient information to understand each
non-GAAP measure. Please revise to provide all the disclosures requested
above
or otherwise remove the non-GAAP statements of operations format from future
filings.
We
will
remove the non-GAAP statements of operations format from future documents furnished
with the SEC.
2.
We
note your disclosure that management uses these measures “to evaluate the
performance period over period and to analyze the underlying trends
on the
Company’s business.” We also note the disclosures that these non-GAAP
measures are the primary indicators management uses for establishing
operational goals and forecasts that are used in allocating resources.
Please confirm that the adjustments reflected in your non-GAAP
measures
are also reflected in, and are consistent with, the measurement
principles
you use to assess segment performance pursuant to SFAS 131. Otherwise,
discuss the reasons for any differences in the two approaches.
We may have
further comments.
The
adjustments excluded from our non-GAAP measures are consistent with those
excluded from our reportable segments’ operating profit (i.e. measure of profit
or loss). These adjustments are not allocated to our reportable segments
and are
excluded from the financial information that our chief operating decision
maker
reviews to make operating decisions and assess performance. As a result,
in our
SFAS 131 annual and quarterly disclosures, the adjustments are a reconciling
item between our reportable segments’ operating profit and our consolidated
operating profit.
However,
the adjustments excluded from our non-GAAP net income/net income per share
are
net of income tax, whereas the adjustments reflected in our SFAS 131 disclosures
are before income tax, per SFAS 131, paragraph 32b.
In
connection with our responses above, we acknowledge the following:
·
we
are responsible for the adequacy and accuracy of the disclosure
in our
filings;
·
staff
comments or changes to disclosure in response to staff comments
do not
foreclose the Commission from taking any action with respect to
the
filing; and
·
we
may not assert staff comments as a defense in any proceeding initiated
by
the Commission or any person under the federal securities laws
of the
United States.
We
hope
that the Staff finds our responses to be reasonable and appropriate. Please
do
not hesitate to contact me directly at (508) 650-8450 with any questions.
Sincerely,
/s/ Lawrence
C. Best
Lawrence
C. Best
Chief
Financial Officer